FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Rodger

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Marc A Rodger
An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients?
K Gauthier; Michael J Kovacs; Marc A Rodger; Philip S Wells; G L E Gal
Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients.
R S Chitsike; M A Crowther; D R Anderson; M T Betancourt; I Chagnon; Michael J Kovacs; G LE Gal; A Perrier; T Ramsay; Marc A Rodger; Susan Solymoss; L M Vickars; P S Wells; Richard H White; Susan R Kahn
Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Rodger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marc A Rodger
An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients?
Thrombosis research 2013;131 Suppl 1():S25-7.
2013: K Gauthier; Michael J Kovacs; Marc A Rodger; Philip S Wells; G L E Gal
Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients.
Journal of thrombosis and haemostasis : JTH 2013;11(1):200-3.
2012: R S Chitsike; M A Crowther; D R Anderson; M T Betancourt; I Chagnon; Michael J Kovacs; G LE Gal; A Perrier; T Ramsay; Marc A Rodger; Susan Solymoss; L M Vickars; P S Wells; Richard H White; Susan R Kahn
Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.
Journal of thrombosis and haemostasis : JTH 2012;10(10):2039-44.
2012: M Tan; C Bornais; Marc A Rodger
Interobserver reliability of compression ultrasound for residual thrombosis after first unprovoked deep vein thrombosis.
Journal of thrombosis and haemostasis : JTH 2012;10(9):1775-82.
2012: Martha L Louzada; Guy Meyer; Timothy O Ramsay; Marc A Rodger; Marc Carrier; Vi Dao; Michael J Kovacs; Alejandro Lazo-Langner; Agnes Y Y Lee; Jerry Zhang; Philip S Wells
Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.
Circulation 2012;126(4):448-54.
2012: J-P Galanaud; C A Holcroft; D R Anderson; M T Betancourt; I Chagnon; M A Crowther; Michael J Kovacs; G Le Gal; A Perrier; T Ramsay; Marc A Rodger; Susan Solymoss; L M Vickars; P S Wells; Richard H White; Susan R Kahn
Comparison of the Villalta post-thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis.
Journal of thrombosis and haemostasis : JTH 2012;10(6):1036-42.
2012: Alejandro Lazo-Langner; Tim Ramsay; Marc A Rodger; Philip S Wells; Nicholas J Barrowman; Douglas A Coyle
Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis.
BMC medical research methodology 2012;12():3.
2011: A Hamadah; Michael J Kovacs; Grégoire LE GAL; T Alwasaidi; Marc Carrier; Melissa A Forgie; C Gonsalves; D Scarvelis; Philip S Wells; Marc A Rodger
Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence.
Journal of thrombosis and haemostasis : JTH 2011;9(12):2406-10.
2011: Martha L Louzada; Marc A Rodger; Monica Taljaard; David R Anderson; Susan R Kahn; Michael J Kovacs; Nicole J Langlois; Philip S Wells
Psychological impact of thrombophilia testing in asymptomatic family members.
Thrombosis research 2011;128(6):530-5.
2011: Karim Abou-Nassar; Marc Carrier; Tim Ramsay; Marc A Rodger
The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis.
Thrombosis research 2011;128(1):77-85.
2011: Marc Carrier; Marc Righini; Marc A Rodger; Philip S Wells; Grégoire LE GAL
Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis.
Journal of thrombosis and haemostasis : JTH 2011;9(6):1119-25.
2011: Grégoire LE GAL; Marc Righini; Susan Solymoss; L Vickars; Philip S Wells; Richard H White; D A Anderson; M T Betancourt; Marc Carrier; I Chagnon; M Crowther; A Delluc; Susan R Kahn; Michael J Kovacs; Marc A Rodger
Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study.
Journal of thrombosis and haemostasis : JTH 2011;9(6):1126-32.
2011: Marc A Rodger
Anticoagulant prophylaxis for placenta mediated pregnancy complications.
Thrombosis research 2011;127 Suppl 3():S76-80.
2010: Marc Carrier; Grégoire LE GAL; Hardy Tao; Philip S Wells; Kim Danovitch; Angele Mbanga-levac; Marc A Rodger
Should we screen patients with unprovoked venous thromboembolism for occult cancers? A pilot study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010;21(7):709-10.
2010: Marc A Rodger; Grégoire LE GAL; Marc Carrier; M T Betancourt; Susan R Kahn; Philip S Wells; D A Anderson; K Lacut; I Chagnon; Susan Solymoss; M Crowther; A Perrier; Richard H White; L Vickars; T Ramsay; Michael J Kovacs
Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.
Thrombosis research 2010;126(3):222-6.
2010: Michael J Kovacs; S R Kahn; Philip S Wells; D A Anderson; I Chagnon; Grégoire LE GAL; Susan Solymoss; M Crowther; A Perrier; T Ramsay; M T Betancourt; Richard H White; L Vickars; Marc A Rodger
Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
Journal of thrombosis and haemostasis : JTH 2010;8(9):1926-32.
2010: Marc Carrier; Marc Righini; Philip S Wells; Arnaud Perrier; David R Anderson; Marc A Rodger; S Pleasance; Grégoire LE GAL
Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies.
Journal of thrombosis and haemostasis : JTH 2010;8(8):1716-22.
2010: Marc A Rodger; Marc Carrier; E Gandara; Grégoire LE GAL
Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit.
Blood reviews 2010;24(4-5):171-8.
2010: Mark A Crowther; David Garcia; Walter Ageno; Luqi Wang; Dan M Witt; Nathan P Clark; Mark D Blostein; Susan R Kahn; Sam Schulman; Michael Kovacs; Marc A Rodger; Philip Wells; David Anderson; Jeffrey Ginsberg; Rita Selby; Sergio Siragusa; Mauro Silingardi; MaryBeth B Dowd; Clive Kearon
Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study.
Thrombosis and haemostasis 2010;104(1):118-21.
2010: Marc A Rodger; Marisol T Betancourt; Peter Clark; Pelle G Lindqvist; Donna Dizon-Townson; Joanne Said; Uri Seligsohn; Marc Carrier; Ophira Salomon; Ian A Greer
The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.
PLoS medicine 2010;7(6):e1000292.
2010: Marc Carrier; Grégoire LE GAL; Philip S Wells; Marc A Rodger
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
Annals of internal medicine 2010;152(9):578-89.
2010: Grégoire LE GAL; Marc Carrier; S Tierney; H Majeed; Marc A Rodger; Philip S Wells
Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
Journal of thrombosis and haemostasis : JTH 2010;8(1):90-4.
2009: Philip S Wells; Martha L Louzada; Monica Taljaard; David R Anderson; Susan R Kahn; Nicole J Langlois; Julie Rutberg; Michael J Kovacs; Marc A Rodger
A pilot study to assess the feasibility of a multicenter cluster randomized trial for the management of asymptomatic persons with a thrombophilia.
Journal of genetic counseling 2009;18(5):475-82.
2009: Vi Dao; Marc A Rodger
Anticoagulants to prevent placenta-mediated pregnancy complications: a review of current evidence.
Current opinion in hematology 2009;16(5):386-90.
2009: Alejandro Lazo-Langner; Marc A Rodger
Overview of current venous thromboembolism protocols in hip reconstruction.
The Orthopedic clinics of North America 2009;40(3):427-36.
2009: Marc Carrier; Grégoire LE GAL; R Cho; S Tierney; Marc A Rodger; Agnes Y Y Lee
Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients.
Journal of thrombosis and haemostasis : JTH 2009;7(5):760-5.
2009: Grégoire LE GAL; Michael J Kovacs; Marc Carrier; K Do; Susan R Kahn; Philip S Wells; D A Anderson; I Chagnon; Susan Solymoss; M Crowther; Marc Righini; A Perrier; Richard H White; L Vickars; Marc A Rodger
Validation of a diagnostic approach to exclude recurrent venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2009;7(5):752-9.
2009: Alejandro Lazo-Langner; Marc A Rodger; Philip S Wells
Lessons from ximelagatran: issues for future studies evaluating new oral direct thrombin inhibitors for venous thromboembolism prophylaxis in orthopedic surgery.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2009;15(3):316-26.
2009: Mark A Crowther; Walter Ageno; David Garcia; Luqi Wang; Dan M Witt; Nathan P Clark; Mark D Blostein; Susan R Kahn; Sara Vesely; Sam Schulman; Michael J Kovacs; Marc A Rodger; Philip Wells; David Anderson; Jeffery Ginsberg; Rita Selby; Sergio Siragusa; Mauro Silingardi; Mary Beth Dowd; Clive Kearon
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
Annals of internal medicine 2009;150(5):293-300.
2009: Marc A Rodger
Thrombophilia and placenta-mediated pregnancy complications: from the bench to bedside to policy.
Thrombosis research 2009;123 Suppl 2():S100-4.
2008: Clive Kearon; Jim A Julian; Michael J Kovacs; David R Anderson; Philip Wells; Betsy MacKinnon; Jeffrey I Weitz; Mark A Crowther; Sean Dolan; Alexander G G Turpie; William Geerts; Susan Solymoss; Paul van Nguyen; Christine Demers; Susan R Kahn; Jeannine Kassis; Marc A Rodger; Julie Hambleton; Michael Gent; Jeffrey S Ginsberg
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.
Blood 2008;112(12):4432-6.
2008: Marc Carrier; Grégoire LE GAL; Philip S Wells; Dean Fergusson; Tim Ramsay; Marc A Rodger
Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?
Annals of internal medicine 2008;149(5):323-33.
2008: Genevieve Le Templier; Marc A Rodger
Heparin-induced osteoporosis and pregnancy.
Current opinion in pulmonary medicine 2008;14(5):403-7.
2008: Marc A Rodger; Susan R Kahn; Philip S Wells; David A Anderson; Isabelle Chagnon; Grégoire LE GAL; Susan Solymoss; Mark Crowther; Arnaud Perrier; Richard H White; Linda Vickars; Tim Ramsay; Marisol T Betancourt; Michael J Kovacs
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;179(5):417-26.
2008: Marc A Rodger; Michael Paidas; Claire McLintock; McLintock Claire; Saskia Middeldorp; Susan Kahn; Ida Martinelli; William Hague; Karen Rosene-Montella; Ian A Greer
Inherited thrombophilia and pregnancy complications revisited.
Obstetrics and gynecology 2008;112(2 Pt 1):320-4.
2008: J Heshka; C Palleschi; Brenda J Wilson; J Brehaut; Julie Rutberg; Holly Etchegary; N Langlois; Marc A Rodger; Philip S Wells
Cognitive and behavioural effects of genetic testing for thrombophilia.
Journal of genetic counseling 2008;17(3):288-96.
2008: Shi Wu Wen; Xi-Kuan Chen; Marc A Rodger; Ruth Rennicks White; Qiuying Yang; Graeme N Smith; Ronald J Sigal; Sherry L Perkins; Mark C Walker
Folic acid supplementation in early second trimester and the risk of preeclampsia.
American journal of obstetrics and gynecology 2008;198(1):45.e1-7.
2008: M Carrier; Marc A Rodger; Dean Fergusson; Steve Doucette; Michael J Kovacs; J Moore; J G Kelton; Greg A Knoll
Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex.
Kidney international 2008;73(2):213-9.
2007: David R Anderson; Susan R Kahn; Marc A Rodger; Michael J Kovacs; Tim Morris; Andrew Hirsch; Eddy Lang; Ian Stiell; George Kovacs; Jonathan Dreyer; Carol Dennie; Yannick Cartier; David Barnes; Erica Burton; Susan Pleasance; Chris Skedgel; Keith O'Rouke; Philip S Wells
Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2007;298(23):2743-53.
2007: Marc A Rodger; Michael Paidas
Do thrombophilias cause placenta-mediated pregnancy complications?
Seminars in thrombosis and hemostasis 2007;33(6):597-603.
2007: Marc A Rodger; Susan R Kahn; A Cranney; Anthony B Hodsman; Michael J Kovacs; A M Clement; Alejandro Lazo-Langner; W M Hague
Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial.
Journal of thrombosis and haemostasis : JTH 2007;5(8):1600-6.
2007: Michael J Kovacs; Susan R Kahn; Marc A Rodger; David R Anderson; R Andreou; J E Mangel; Beverly Morrow; A M Clement; Philip S Wells
A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study).
Journal of thrombosis and haemostasis : JTH 2007;5(8):1650-3.
2007: Karim Abou-Nassar; Michael J Kovacs; Susan R Kahn; Philip Wells; Steve Doucette; Tim Ramsay; Anne Marie Clement; Rshmi Khurana; Karen MacKinnon; Mark Blostein; Susan Solymoss; John Kingdom; Mathew Sermer; Evelyne Rey; Marc A Rodger
The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Thrombosis and haemostasis 2007;98(1):163-71.
2007: Alejandro Lazo-Langner; Glenwood Goss; Johanna N Spaans; Marc A Rodger
The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials.
Journal of thrombosis and haemostasis : JTH 2007;5(4):729-37.
2007: Susan R Kahn; Hadia Shbaklo; Stan Shapiro; Philip S Wells; Michael J Kovacs; Marc A Rodger; David R Anderson; Jeffrey S Ginsberg; Mira Johri; Vicky Tagalakis
Effectiveness of compression stockings to prevent the post-thrombotic syndrome (the SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial.
BMC cardiovascular disorders 2007;7():21.
2007: Marc Carrier; Greg A Knoll; Michael J Kovacs; Jane C Moore; Dean Fergusson; Marc A Rodger
The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Thrombosis research 2007;120(2):215-20.
2006: Alejandro Lazo-Langner; Greg A Knoll; Philip S Wells; Nancy L Carson; Marc A Rodger
The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene.
Blood 2006;108(13):4052-8.
2006: Philip S Wells; Josdalyne L Anderson; Marc A Rodger; Nancy L Carson; Rebecca L Grimwood; Steve Doucette
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2006;17(7):533-8.
2006: Marc A Rodger; Leonard I Avruch; Heather E A Howley; Andre Olivier; Mark C Walker
Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section.
American journal of obstetrics and gynecology 2006;194(2):436-7.
2006: Michael J Kovacs; Judy Kovacs; J Anderson; Marc A Rodger; Karen MacKinnon; Philip S Wells
Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism.
Clinical and laboratory haematology 2006;28(1):9-13.
2006: Marc A Rodger; Christopher N Bredeson; Gwynne Jones; Pasteur Rasuli; François Raymond; Anne Marie Clement; Alan Karovitch; Helene Brunette; Dimitri Makropoulos; Mark Reardon; Ian Stiell; Rama Nair; Philip S Wells
The bedside investigation of pulmonary embolism diagnosis study: a double-blind randomized controlled trial comparing combinations of 3 bedside tests vs ventilation-perfusion scan for the initial investigation of suspected pulmonary embolism.
Archives of internal medicine 2006;166(2):181-7.
2006: Marc Carrier; Philip S Wells; Marc A Rodger
Excluding pulmonary embolism at the bedside with low pre-test probability and D-dimer: safety and clinical utility of 4 methods to assign pre-test probability.
Thrombosis research 2006;117(4):469-74.
2005: Philip S Wells; David R Anderson; Marc A Rodger; Melissa A Forgie; Peggy Florack; Donna Touchie; Beverly Morrow; Lisa Gray; Keith O'Rourke; George Wells; Judy Kovacs; Michael J Kovacs
A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
Archives of internal medicine 2005;165(7):733-8.
2005: Susan R Kahn; Clive Kearon; Jim A Julian; Betsy MacKinnon; Michael J Kovacs; Philip Wells; Mark A Crowther; David R Anderson; Paul van Nguyen; Christine Demers; Susan Solymoss; Jeannine Kassis; William Geerts; Marc A Rodger; J Hambleton; Jeffrey S Ginsberg
Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(4):718-23.
2005: Greg A Knoll; Philip S Wells; Darlene Young; Sherry L Perkins; Rachel M Pilkey; Jennifer Clinch; Marc A Rodger
Thrombophilia and the risk for hemodialysis vascular access thrombosis.
Journal of the American Society of Nephrology : JASN 2005;16(4):1108-14.
2005: Heather E A Howley; Mark Walker; Marc A Rodger
A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction.
American journal of obstetrics and gynecology 2005;192(3):694-708.
2005: Marc A Rodger; Elana Maser; Ian Stiell; Heather E A Howley; Philip S Wells
The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism.
Thrombosis research 2005;116(2):101-7.
2004: Michael J Kovacs; Clive Kearon; Marc A Rodger; David R Anderson; Alexander G G Turpie; Shannon M Bates; L Desjardins; James D Douketis; Susan R Kahn; Susan Solymoss; P S Wells
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Circulation 2004;110(12):1658-63.
2003: Philip S Wells; Marc A Rodger; Melissa A Forgie; Nicole J Langlois; Linlea Armstrong; Nancy L Carson; James Jaffey
The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism.
Thrombosis and haemostasis 2003;90(5):829-34.
2003: Philip S Wells; David R Anderson; Marc A Rodger; Melissa A Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.
The New England journal of medicine 2003;349(13):1227-35.
2003: Clive Kearon; Jeffrey S Ginsberg; Michael J Kovacs; David R Anderson; Philip Wells; Jim A Julian; Betsy MacKinnon; Jeffrey I Weitz; Mark A Crowther; Sean Dolan; Alexander G G Turpie; William Geerts; Susan Solymoss; Paul van Nguyen; Christine Demers; Susan R Kahn; Jeannine Kassis; Marc A Rodger; Julie Hambleton; Michael Gent
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
The New England journal of medicine 2003;349(7):631-9.
2003: Marc A Rodger; Marc Carrier; Muriel Gervais; Gail Rock
Normal functional protein S activity does not exclude protein S deficiency.
Pathophysiology of haemostasis and thrombosis 2003;33(4):202-5.
2003: Marc A Rodger; Mark Walker; Philip S Wells
Diagnosis and treatment of venous thromboembolism in pregnancy.
Best practice & research. Clinical haematology 2003;16(2):279-96.
2003: Michael J Kovacs; Marc A Rodger; David R Anderson; Beverly Morrow; Gertrude Kells; Judy Kovacs; Eleanor Boyle; Philip S Wells
Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.
Annals of internal medicine 2003;138(9):714-9.
2003: Philip S Wells; Melissa A Forgie; Maureen Simms; Alison Greene; Donna Touchie; Geoffrey Lewis; Jodi Anderson; Marc A Rodger
The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
Archives of internal medicine 2003;163(8):917-20.
2003: Philip S Wells; Marc A Rodger
Diagnosis of pulmonary embolism: when is imaging needed?
Clinics in chest medicine 2003;24(1):13-28.
2003: Marc A Rodger; Dimitri Makropoulos; Mark Walker; Erin Keely; Alan Karovitch; Philip S Wells
Participation of pregnant women in clinical trials: will they participate and why?
American journal of perinatology 2003;20(2):69-76.
2003: Marc A Rodger; Christine Gagné-Rodger; Heather E A Howley; Marc Carrier; Douglas Coyle; Philip S Wells
The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
Thrombosis research 2003;112(1-2):13-8.
2002: Marc A Rodger; Marc Carrier; Erin Keely; Alan Karovitch; Carl Nimrod; Mark Walker; Philip S Wells
The management of thrombophilia during pregnancy: a Canadian survey.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC 2002;24(12):946-52.
2001: Marc A Rodger; Philip S Wells
Diagnosis of pulmonary embolism.
Thrombosis research 2001;103(6):V225-38.
2001: Philip S Wells; David R Anderson; Marc A Rodger; Ian Stiell; Jonathan Dreyer; D Barnes; Melissa A Forgie; George Kovacs; J Ward; Michael J Kovacs
Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer.
Annals of internal medicine 2001;135(2):98-107.
2001: Marc A Rodger; Gwynne Jones; Pasteur Rasuli; François Raymond; H Djunaedi; Christopher N Bredeson; Philip S Wells
Steady-state end-tidal alveolar dead space fraction and D-dimer: bedside tests to exclude pulmonary embolism.
Chest 2001;120(1):115-9.
2000: Marc A Rodger; M Carrier; G N Jones; Pasteur Rasuli; François Raymond; H Djunaedi; Philip S Wells
Diagnostic value of arterial blood gas measurement in suspected pulmonary embolism.
American journal of respiratory and critical care medicine 2000;162(6):2105-8.
2000: Marc A Rodger; Dimitri Makropoulos; Michele A Turek; J Quevillon; François Raymond; Pasteur Rasuli; Philip S Wells
Diagnostic value of the electrocardiogram in suspected pulmonary embolism.
The American journal of cardiology 2000;86(7):807-9, A10.
2000: Philip S Wells; David R Anderson; Marc A Rodger; Jeffrey S Ginsberg; Clive Kearon; Michael Gent; Alexander G G Turpie; Janis Bormanis; J Weitz; M Chamberlain; D Bowie; D Barnes; Jack Hirsh
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer.
Thrombosis and haemostasis 2000;83(3):416-20.
1998: Marc A Rodger; Christopher N Bredeson; Philip S Wells; J Beck; B Kearns; Lothar Huebsch
Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1998;159(8):931-8.
1998: Marc A Rodger; Gwynne Jones; François Raymond; D Lalonde; M Proulx; Lothar Huebsch; Christopher N Bredeson
Dead space ventilation parallels changes in scintigraphic vascular obstruction at recurrence of pulmonary embolism and after thrombolytic therapy: a case report.
Canadian respiratory journal : journal of the Canadian Thoracic Society 1998;5(3):215-8.